Linking the future of anticancer metal-complexes to the therapy of tumour metastases
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Linking the future of anticancer metal-complexes to the therapy of tumour metastases
Authors
Keywords
-
Journal
CHEMICAL SOCIETY REVIEWS
Volume 44, Issue 24, Pages 8818-8835
Publisher
Royal Society of Chemistry (RSC)
Online
2015-03-28
DOI
10.1039/c5cs00134j
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activation of p53 mediated glycolytic inhibition-oxidative stress-apoptosis pathway in Dalton's lymphoma by a ruthenium (II)-complex containing 4-carboxy N-ethylbenzamide
- (2015) Raj Kumar Koiri et al. BIOCHIMIE
- Antiangiogenic ruthenium(ii) benzimidazole complexes, structure-based activation of distinct signaling pathways
- (2015) Haoqiang Lai et al. Metallomics
- Src activity is modulated by oxaliplatin and correlates with outcomes after hepatectomy for metastatic colorectal cancer
- (2014) Scott Kopetz et al. BMC CANCER
- Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer
- (2014) A F Hezel et al. BRITISH JOURNAL OF CANCER
- Effects of polymorphisms in the XRCC1, XRCC3, and XPG genes on clinical outcomes of platinum-based chemotherapy for treatment of non-small cell lung cancer
- (2014) Z.Y. Jin et al. GENETICS AND MOLECULAR RESEARCH
- Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer
- (2014) N.G. Alkema et al. GYNECOLOGIC ONCOLOGY
- Inhibition of α4β1 integrin increases ovarian cancer response to carboplatin
- (2014) Jennifer M. Scalici et al. GYNECOLOGIC ONCOLOGY
- Preclinical combination therapy of the investigational drug NAMI-A+ with doxorubicin for mammary cancer
- (2014) Alberta Bergamo et al. INVESTIGATIONAL NEW DRUGS
- Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
- (2014) Suzanne Leijen et al. INVESTIGATIONAL NEW DRUGS
- Arene ruthenium(ii) complex, a potent inhibitor against proliferation, migration and invasion of breast cancer cells, reduces stress fibers, focal adhesions and invadopodia
- (2014) Qiong Wu et al. Metallomics
- Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status
- (2014) Shikha Gaur et al. Molecular Cancer
- BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasis
- (2014) Mateusz Rytelewski et al. Molecular Oncology
- BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin
- (2014) B T Paul et al. ONCOGENE
- Epithelial–mesenchymal status renders differential responses to cisplatin in ovarian cancer
- (2014) Q H Miow et al. ONCOGENE
- Oxaliplatin-Based Chemotherapy Is More Beneficial in KRAS Mutant than in KRAS Wild-Type Metastatic Colorectal Cancer Patients
- (2014) Yu-Lin Lin et al. PLoS One
- Upregulation of miR-21 in Cisplatin Resistant Ovarian Cancer via JNK-1/c-Jun Pathway
- (2014) Ileabett M. Echevarría-Vargas et al. PLoS One
- Withaferin A Alone and in Combination with Cisplatin Suppresses Growth and Metastasis of Ovarian Cancer by Targeting Putative Cancer Stem Cells
- (2014) Sham S. Kakar et al. PLoS One
- In vivo anti-tumor activity of the organometallic ruthenium(ii)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas
- (2014) Andrea Weiss et al. Chemical Science
- Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis
- (2014) Dinesh Vyas et al. OncoTargets and Therapy
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Targeted Inhibition of mTOR Signaling Improves Sensitivity of Esophageal Squamous Cell Carcinoma Cells to Cisplatin
- (2014) Guiqin Hou et al. Journal of Immunology Research
- Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?
- (2014) Christen L Walters Haygood World Journal of Stem Cells
- Combination therapy with carboplatin and thalidomide suppresses tumor growth and metastasis in 4T1 murine breast cancer model
- (2013) Cristina Maria de Souza et al. BIOMEDICINE & PHARMACOTHERAPY
- Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells
- (2013) Hana Janouskova et al. CANCER LETTERS
- Mechanisms Governing Metastatic Dormancy and Reactivation
- (2013) Filippo G. Giancotti CELL
- Effects of chrysin, apigenin, genistein and their homoleptic copper(II) complexes on the growth and metastatic potential of cancer cells
- (2013) Cornelia Spoerlein et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Imaging VCAM-1 as an Indicator of Treatment Efficacy in Metastatic Ovarian Cancer
- (2013) J. M. Scalici et al. JOURNAL OF NUCLEAR MEDICINE
- Impacts of fullerene derivatives on regulating the structure and assembly of collagen molecules
- (2013) Xiaohui Yin et al. Nanoscale
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients
- (2013) Mario Scartozzi et al. PHARMACOGENOMICS
- Epimorphin-Induced MET Sensitizes Ovarian Cancer Cells to Platinum
- (2013) Kok-Hooi Yew et al. PLoS One
- Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
- (2013) M. Yu et al. SCIENCE
- Role of ABCG2 expression driven by cisplatin in platinum-containing chemotherapy for gastric cancer
- (2013) Qiang Zhang WORLD JOURNAL OF GASTROENTEROLOGY
- Docetaxel–cisplatin might be superior to docetaxel–capecitabine in the first-line treatment of metastatic triple-negative breast cancer†
- (2012) Y. Fan et al. ANNALS OF ONCOLOGY
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
- (2012) H. J. Schmoll et al. ANNALS OF ONCOLOGY
- Anti-metastatic and Anti-angiogenic Properties of Potential New Anti-cancer Drugs Based on Metal Complexes of Selenosemicarbazones
- (2012) Manja Zec et al. Anti-Cancer Agents in Medicinal Chemistry
- CDK1 Hyperphosphorylation Maintenance Drives the Time-course of G2-M Cell Cycle Arrest after Short Treatment with NAMI-A in Kb Cells
- (2012) Alberta Bergamo et al. Anti-Cancer Agents in Medicinal Chemistry
- Evaluation of survival benefits by platinums and taxanes for an unfavourable subset of carcinoma of unknown primary: a systematic review and meta-analysis
- (2012) J Lee et al. BRITISH JOURNAL OF CANCER
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells
- (2012) Jade B. Aitken et al. Metallomics
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
- (2012) Timothy R. Wilson et al. NATURE
- Combinatorial drug therapy for cancer in the post-genomic era
- (2012) Bissan Al-Lazikani et al. NATURE BIOTECHNOLOGY
- Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
- (2012) Wan Zhang et al. NATURE CELL BIOLOGY
- A family business: stem cell progeny join the niche to regulate homeostasis
- (2012) Ya-Chieh Hsu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Bone Marrow Stromal Cells Modulate Mouse ENT1 Activity and Protect Leukemia Cells from Cytarabine Induced Apoptosis
- (2012) Patricia Macanas-Pirard et al. PLoS One
- Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial
- (2011) A. Flechon et al. ANNALS OF ONCOLOGY
- Developmental and Pathological Angiogenesis
- (2011) Alicia S. Chung et al. Annual Review of Cell and Developmental Biology
- A cyclopalladated complex interacts with mitochondrial membrane thiol-groups and induces the apoptotic intrinsic pathway in murine and cisplatin-resistant human tumor cells
- (2011) Fabiana A Serrano et al. BMC CANCER
- Macrophage Binding to Receptor VCAM-1 Transmits Survival Signals in Breast Cancer Cells that Invade the Lungs
- (2011) Qing Chen et al. CANCER CELL
- Loss or Inhibition of Stromal-Derived PlGF Prolongs Survival of Mice with Imatinib-Resistant Bcr-Abl1+ Leukemia
- (2011) Thomas Schmidt et al. CANCER CELL
- Bone Marrow Stroma-Secreted Cytokines Protect JAK2V617F-Mutated Cells from the Effects of a JAK2 Inhibitor
- (2011) T. Manshouri et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Dialkyl Bisphosphonate Platinum(II) Complex as a Potential Drug for Metastatic Bone Tumor
- (2011) Hidetoshi Nakatake et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs
- (2011) Alberta Bergamo et al. DALTON TRANSACTIONS
- Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer
- (2011) T. Shree et al. GENES & DEVELOPMENT
- Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
- (2011) Sergio A. Quezada et al. IMMUNOLOGICAL REVIEWS
- Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial
- (2011) Matthew T Seymour et al. LANCET
- Role of stromal microenvironment in nonpharmacological resistance of CML to imatinib through Lyn/CXCR4 interactions in lipid rafts
- (2011) Y Tabe et al. LEUKEMIA
- Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin
- (2011) Michael Groessl et al. Metallomics
- Fibroblasts Contribute to Melanoma Tumor Growth and Drug Resistance
- (2011) Edward H. Flach et al. MOLECULAR PHARMACEUTICS
- Drug Resistance and Cellular Adaptation to Tumor Acidic pH Microenvironment
- (2011) Jonathan W. Wojtkowiak et al. MOLECULAR PHARMACEUTICS
- KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma
- (2011) T Jiffar et al. ONCOGENE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Microenvironmental Influence on Pre-Clinical Activity of Polo-Like Kinase Inhibition in Multiple Myeloma: Implications for Clinical Translation
- (2011) Douglas W. McMillin et al. PLoS One
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Sublethal concentrations of the platinum(II) complex [Pt(O,O′-acac)(γ-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells
- (2010) Antonella Muscella et al. BRITISH JOURNAL OF PHARMACOLOGY
- Gold(III) porphyrin 1a inhibited nasopharyngeal carcinoma metastasis in vivo and inhibited cell migration and invasion in vitro
- (2010) Ching Tung Lum et al. CANCER LETTERS
- Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment
- (2010) N. Chan et al. CANCER RESEARCH
- Platinum-DNA Interactions and Subsequent Cellular Processes Controlling Sensitivity to Anticancer Platinum Complexes
- (2010) Saeed Ahmad CHEMISTRY & BIODIVERSITY
- Neoplastic stem cells: Current concepts and clinical perspectives
- (2010) Axel Schulenburg et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer
- (2010) N. Ahmed et al. CURRENT CANCER DRUG TARGETS
- The status of platinum anticancer drugs in the clinic and in clinical trials
- (2010) Nial J. Wheate et al. DALTON TRANSACTIONS
- Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma
- (2010) Pasqualino Malandrino et al. ENDOCRINE-RELATED CANCER
- Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice
- (2010) Mitomu Kioi et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma
- (2010) Jo Eyles et al. JOURNAL OF CLINICAL INVESTIGATION
- Synthesis, structure and characterization of novel Cd(II) and Zn(II) complexes with the condensation product of 2-formylpyridine and selenosemicarbazide
- (2010) Snežana Bjelogrlić et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Organometallic ruthenium-based antitumor compounds with novel modes of action
- (2010) Wee Han Ang et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- Arsenic Trioxide overcomes cell adhesion-mediated drug resistance through down-regulating the expression of β1-integrin in K562 chronic myelogenous leukemia cell line
- (2010) Wang Guo-Bao et al. LEUKEMIA & LYMPHOMA
- Tumor cell-specific bioluminescence platform to identify stroma-induced changes to anticancer drug activity
- (2010) Douglas W McMillin et al. NATURE MEDICINE
- Effects of Bone Marrow Stromal Cells and Umbilical Cord Blood-Derived Stromal Cells on Daunorubicin-Resistant Residual Jurkat Cells
- (2010) X. Liang et al. TRANSPLANTATION PROCEEDINGS
- Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
- (2009) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Pharmacokinetics of a novel anticancer ruthenium complex (KP1019, FFC14A) in a phase I dose-escalation study
- (2009) Frederike Lentz et al. ANTI-CANCER DRUGS
- Mechanisms of anti-cancer action and pharmacology of clofarabine
- (2009) Anna Zhenchuk et al. BIOCHEMICAL PHARMACOLOGY
- Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells
- (2009) D L Roberts et al. BRITISH JOURNAL OF CANCER
- Acute myelogenous leukemia
- (2009) Joshua L. Shipley et al. EXPERIMENTAL HEMATOLOGY
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine
- (2008) A C Dudley et al. BRITISH JOURNAL OF CANCER
- Phase II evaluation of nedaplatin and paclitaxel in patients with metastatic esophageal carcinoma
- (2008) Youling Gong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Subtypes of Breast Cancer Show Preferential Site of Relapse
- (2008) M. Smid et al. CANCER RESEARCH
- Targeted therapeutics for cancer treatment: major progress towards personalised molecular medicine
- (2008) Paul Workman et al. CURRENT OPINION IN PHARMACOLOGY
- A 1,2-d(GpG) Cisplatin Intrastrand Cross-Link Influences the Rotational and Translational Setting of DNA in Nucleosomes
- (2008) Matthias Ober et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival
- (2008) Bijan Moshaver et al. LEUKEMIA & LYMPHOMA
- Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance
- (2008) Nadine N. Bewry et al. MOLECULAR CANCER THERAPEUTICS
- ATF6 -Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo
- (2008) D. M. Schewe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More